Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA)

Mami Takahashi, Masato Fukutake, Takashi Isoi, Kazunori Fukuda, Hidetaka Sato, Kazunaga Yazawa, Takashi Sugimura, Keiji Wakabayashi

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The effects of intragastric gavage administration of docosahexaenoic acid (DNA), a major component of fish oil, on azoxymethane (AOM)-induced colon carcinogenesis in rats was investigated. Male F344 rats were treated with 15 mg/kg body wt of AOM once a week, for two weeks. The animals were given either 1 ml of DHA or water intragastrically 5 times a week, starting the day before the first carcinogen treatment. The numbers of AOM-induced aberrant crypt foci in the rats given DHA were 76% and 62% of the control values, at 4 and 12 weeks, respectively. After 36 weeks of DHA treatment, colon tumors were counted and examined histologically. The blood plasma levels of prostaglandin E2 (PGE2) and polyunsaturated fatty acids were also quantified. The incidences of colon cancer did not differ, being 96% and 92% in the AOM and AOM + DHA groups, respectively. Colon cancer multiplicity was, however, significantly decreased by the DHA treatment; 3.65 ± 2.18 in the AOM group and 2.41 ± 1.58 in the AOM + DHA group (P < 0.01). Notably, the numbers of moderately differentiated adenocarcinomas in the middle and distal colon in the DHA-treated group were lower than in the AOM group. The levels of PGE2 and arachidonic acid in the blood plasma of DHA-treated rats were also significantly lower than in the AOM group. These results suggest that DHA exerts its inhibitory effect on colon carcinogenesis by modulating lipid metabolism and inhibiting the arachidonic cascade.

Original languageEnglish
Pages (from-to)1337-1342
Number of pages6
JournalCarcinogenesis
Volume18
Issue number7
DOIs
Publication statusPublished - 1997 Jul
Externally publishedYes

Fingerprint

Azoxymethane
Docosahexaenoic Acids
Fish Oils
Colon
Carcinoma
Dinoprostone
Colonic Neoplasms
Carcinogenesis
Aberrant Crypt Foci
Inbred F344 Rats
Unsaturated Fatty Acids
Lipid Metabolism
Arachidonic Acid
Carcinogens
Adenocarcinoma

ASJC Scopus subject areas

  • Cancer Research

Cite this

Takahashi, M., Fukutake, M., Isoi, T., Fukuda, K., Sato, H., Yazawa, K., ... Wakabayashi, K. (1997). Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis, 18(7), 1337-1342. https://doi.org/10.1093/carcin/18.7.1337

Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). / Takahashi, Mami; Fukutake, Masato; Isoi, Takashi; Fukuda, Kazunori; Sato, Hidetaka; Yazawa, Kazunaga; Sugimura, Takashi; Wakabayashi, Keiji.

In: Carcinogenesis, Vol. 18, No. 7, 07.1997, p. 1337-1342.

Research output: Contribution to journalArticle

Takahashi, M, Fukutake, M, Isoi, T, Fukuda, K, Sato, H, Yazawa, K, Sugimura, T & Wakabayashi, K 1997, 'Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA)', Carcinogenesis, vol. 18, no. 7, pp. 1337-1342. https://doi.org/10.1093/carcin/18.7.1337
Takahashi, Mami ; Fukutake, Masato ; Isoi, Takashi ; Fukuda, Kazunori ; Sato, Hidetaka ; Yazawa, Kazunaga ; Sugimura, Takashi ; Wakabayashi, Keiji. / Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). In: Carcinogenesis. 1997 ; Vol. 18, No. 7. pp. 1337-1342.
@article{2f9adee393444e64abd26a8a4434f922,
title = "Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA)",
abstract = "The effects of intragastric gavage administration of docosahexaenoic acid (DNA), a major component of fish oil, on azoxymethane (AOM)-induced colon carcinogenesis in rats was investigated. Male F344 rats were treated with 15 mg/kg body wt of AOM once a week, for two weeks. The animals were given either 1 ml of DHA or water intragastrically 5 times a week, starting the day before the first carcinogen treatment. The numbers of AOM-induced aberrant crypt foci in the rats given DHA were 76{\%} and 62{\%} of the control values, at 4 and 12 weeks, respectively. After 36 weeks of DHA treatment, colon tumors were counted and examined histologically. The blood plasma levels of prostaglandin E2 (PGE2) and polyunsaturated fatty acids were also quantified. The incidences of colon cancer did not differ, being 96{\%} and 92{\%} in the AOM and AOM + DHA groups, respectively. Colon cancer multiplicity was, however, significantly decreased by the DHA treatment; 3.65 ± 2.18 in the AOM group and 2.41 ± 1.58 in the AOM + DHA group (P < 0.01). Notably, the numbers of moderately differentiated adenocarcinomas in the middle and distal colon in the DHA-treated group were lower than in the AOM group. The levels of PGE2 and arachidonic acid in the blood plasma of DHA-treated rats were also significantly lower than in the AOM group. These results suggest that DHA exerts its inhibitory effect on colon carcinogenesis by modulating lipid metabolism and inhibiting the arachidonic cascade.",
author = "Mami Takahashi and Masato Fukutake and Takashi Isoi and Kazunori Fukuda and Hidetaka Sato and Kazunaga Yazawa and Takashi Sugimura and Keiji Wakabayashi",
year = "1997",
month = "7",
doi = "10.1093/carcin/18.7.1337",
language = "English",
volume = "18",
pages = "1337--1342",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA)

AU - Takahashi, Mami

AU - Fukutake, Masato

AU - Isoi, Takashi

AU - Fukuda, Kazunori

AU - Sato, Hidetaka

AU - Yazawa, Kazunaga

AU - Sugimura, Takashi

AU - Wakabayashi, Keiji

PY - 1997/7

Y1 - 1997/7

N2 - The effects of intragastric gavage administration of docosahexaenoic acid (DNA), a major component of fish oil, on azoxymethane (AOM)-induced colon carcinogenesis in rats was investigated. Male F344 rats were treated with 15 mg/kg body wt of AOM once a week, for two weeks. The animals were given either 1 ml of DHA or water intragastrically 5 times a week, starting the day before the first carcinogen treatment. The numbers of AOM-induced aberrant crypt foci in the rats given DHA were 76% and 62% of the control values, at 4 and 12 weeks, respectively. After 36 weeks of DHA treatment, colon tumors were counted and examined histologically. The blood plasma levels of prostaglandin E2 (PGE2) and polyunsaturated fatty acids were also quantified. The incidences of colon cancer did not differ, being 96% and 92% in the AOM and AOM + DHA groups, respectively. Colon cancer multiplicity was, however, significantly decreased by the DHA treatment; 3.65 ± 2.18 in the AOM group and 2.41 ± 1.58 in the AOM + DHA group (P < 0.01). Notably, the numbers of moderately differentiated adenocarcinomas in the middle and distal colon in the DHA-treated group were lower than in the AOM group. The levels of PGE2 and arachidonic acid in the blood plasma of DHA-treated rats were also significantly lower than in the AOM group. These results suggest that DHA exerts its inhibitory effect on colon carcinogenesis by modulating lipid metabolism and inhibiting the arachidonic cascade.

AB - The effects of intragastric gavage administration of docosahexaenoic acid (DNA), a major component of fish oil, on azoxymethane (AOM)-induced colon carcinogenesis in rats was investigated. Male F344 rats were treated with 15 mg/kg body wt of AOM once a week, for two weeks. The animals were given either 1 ml of DHA or water intragastrically 5 times a week, starting the day before the first carcinogen treatment. The numbers of AOM-induced aberrant crypt foci in the rats given DHA were 76% and 62% of the control values, at 4 and 12 weeks, respectively. After 36 weeks of DHA treatment, colon tumors were counted and examined histologically. The blood plasma levels of prostaglandin E2 (PGE2) and polyunsaturated fatty acids were also quantified. The incidences of colon cancer did not differ, being 96% and 92% in the AOM and AOM + DHA groups, respectively. Colon cancer multiplicity was, however, significantly decreased by the DHA treatment; 3.65 ± 2.18 in the AOM group and 2.41 ± 1.58 in the AOM + DHA group (P < 0.01). Notably, the numbers of moderately differentiated adenocarcinomas in the middle and distal colon in the DHA-treated group were lower than in the AOM group. The levels of PGE2 and arachidonic acid in the blood plasma of DHA-treated rats were also significantly lower than in the AOM group. These results suggest that DHA exerts its inhibitory effect on colon carcinogenesis by modulating lipid metabolism and inhibiting the arachidonic cascade.

UR - http://www.scopus.com/inward/record.url?scp=0031410749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031410749&partnerID=8YFLogxK

U2 - 10.1093/carcin/18.7.1337

DO - 10.1093/carcin/18.7.1337

M3 - Article

C2 - 9230276

AN - SCOPUS:0031410749

VL - 18

SP - 1337

EP - 1342

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 7

ER -